Suivi Thérapeutique Pharmacologique des inhibiteurs de point de contrôle de l'immunité: quel niveau de preuve? Article Swipe

View

Joseph Ciccolini ·

YOU? · · 2024 · Open Access ·

National audience

Related Topics

Philosophy

Concepts

Philosophy

Metadata

Type: article
Language: fr
Landing Page: https://inria.hal.science/hal-04825892
OA Status: green
OpenAlex ID: https://openalex.org/W4405418926

All OpenAlex metadata

Raw OpenAlex JSON

OpenAlex ID: https://openalex.org/W4405418926

Canonical identifier for this work in OpenAlex
Title: Suivi Thérapeutique Pharmacologique des inhibiteurs de point de contrôle de l'immunité: quel niveau de preuve?

Work title
Type: article

OpenAlex work type
Language: fr

Primary language
Publication year: 2024

Year of publication
Publication date: 2024-10-01

Full publication date if available
Authors: Joseph Ciccolini

List of authors in order
Landing page: https://inria.hal.science/hal-04825892

Publisher landing page
Open access: Yes

Whether a free full text is available
OA status: green

Open access status per OpenAlex
OA URL: https://inria.hal.science/hal-04825892

Direct OA link when available
Concepts: Philosophy

Top concepts (fields/topics) attached by OpenAlex
Cited by: 0

Total citation count in OpenAlex

Full payload

id	https://openalex.org/W4405418926
doi
ids.openalex	https://openalex.org/W4405418926
fwci	0.0
type	article
title	Suivi Thérapeutique Pharmacologique des inhibiteurs de point de contrôle de l'immunité: quel niveau de preuve?
biblio.issue
biblio.volume
biblio.last_page
biblio.first_page
topics[0].id	https://openalex.org/T11157
topics[0].field.id	https://openalex.org/fields/27
topics[0].field.display_name	Medicine
topics[0].score	0.9812999963760376
topics[0].domain.id	https://openalex.org/domains/4
topics[0].domain.display_name	Health Sciences
topics[0].subfield.id	https://openalex.org/subfields/2716
topics[0].subfield.display_name	Genetics
topics[0].display_name	Chronic Lymphocytic Leukemia Research
topics[1].id	https://openalex.org/T12817
topics[1].field.id	https://openalex.org/fields/30
topics[1].field.display_name	Pharmacology, Toxicology and Pharmaceutics
topics[1].score	0.9629999995231628
topics[1].domain.id	https://openalex.org/domains/1
topics[1].domain.display_name	Life Sciences
topics[1].subfield.id	https://openalex.org/subfields/3004
topics[1].subfield.display_name	Pharmacology
topics[1].display_name	Pharmacological Effects of Natural Compounds
topics[2].id	https://openalex.org/T11725
topics[2].field.id	https://openalex.org/fields/24
topics[2].field.display_name	Immunology and Microbiology
topics[2].score	0.9325000047683716
topics[2].domain.id	https://openalex.org/domains/1
topics[2].domain.display_name	Life Sciences
topics[2].subfield.id	https://openalex.org/subfields/2403
topics[2].subfield.display_name	Immunology
topics[2].display_name	Immunodeficiency and Autoimmune Disorders
is_xpac	False
apc_list
apc_paid
concepts[0].id	https://openalex.org/C138885662
concepts[0].level	0
concepts[0].score	0.28989580273628235
concepts[0].wikidata	https://www.wikidata.org/wiki/Q5891
concepts[0].display_name	Philosophy
keywords[0].id	https://openalex.org/keywords/philosophy
keywords[0].score	0.28989580273628235
keywords[0].display_name	Philosophy
language	fr
locations[0].id	pmh:oai:HAL:hal-04825892v1
locations[0].is_oa	True
locations[0].source.id	https://openalex.org/S4306402512
locations[0].source.issn
locations[0].source.type	repository
locations[0].source.is_oa	False
locations[0].source.issn_l
locations[0].source.is_core	False
locations[0].source.is_in_doaj	False
locations[0].source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
locations[0].source.host_organization	https://openalex.org/I1294671590
locations[0].source.host_organization_name	Centre National de la Recherche Scientifique
locations[0].source.host_organization_lineage	https://openalex.org/I1294671590
locations[0].license	cc-by
locations[0].pdf_url
locations[0].version	submittedVersion
locations[0].raw_type	Conference papers
locations[0].license_id	https://openalex.org/licenses/cc-by
locations[0].is_accepted	False
locations[0].is_published	False
locations[0].raw_source_name	Journée d’innovation en immunologie, BIOSYNEX, Oct 2024, Paris, France
locations[0].landing_page_url	https://inria.hal.science/hal-04825892
authorships[0].author.id	https://openalex.org/A5088425379
authorships[0].author.orcid	https://orcid.org/0000-0003-1733-3410
authorships[0].author.display_name	Joseph Ciccolini
authorships[0].countries	FR
authorships[0].affiliations[0].institution_ids	https://openalex.org/I4210106545
authorships[0].affiliations[0].raw_affiliation_string	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
authorships[0].institutions[0].id	https://openalex.org/I4210106545
authorships[0].institutions[0].ror	https://ror.org/01nzkaw91
authorships[0].institutions[0].type	government
authorships[0].institutions[0].lineage	https://openalex.org/I1326498283, https://openalex.org/I201841394, https://openalex.org/I4210106545
authorships[0].institutions[0].country_code	FR
authorships[0].institutions[0].display_name	Research Centre Inria Sophia Antipolis - Méditerranée
authorships[0].author_position	first
authorships[0].raw_author_name	Joseph Ciccolini
authorships[0].is_corresponding	True
authorships[0].raw_affiliation_strings	COMPO - Méthodes computationnelles pour la prise en charge thérapeutique en oncologie : Optimisation des stratégies par modélisation mécaniste et statistique (Inria Sophia Antipolis Méditerranée 2004 Route des Lucioles 06902 Valbonne - France)
has_content.pdf	False
has_content.grobid_xml	False
is_paratext	False
open_access.is_oa	True
open_access.oa_url	https://inria.hal.science/hal-04825892
open_access.oa_status	green
open_access.any_repository_has_fulltext	False
created_date	2025-10-10T00:00:00
display_name	Suivi Thérapeutique Pharmacologique des inhibiteurs de point de contrôle de l'immunité: quel niveau de preuve?
has_fulltext	False
is_retracted	False
updated_date	2025-11-06T04:12:42.849631
primary_topic.id	https://openalex.org/T11157
primary_topic.field.id	https://openalex.org/fields/27
primary_topic.field.display_name	Medicine
primary_topic.score	0.9812999963760376
primary_topic.domain.id	https://openalex.org/domains/4
primary_topic.domain.display_name	Health Sciences
primary_topic.subfield.id	https://openalex.org/subfields/2716
primary_topic.subfield.display_name	Genetics
primary_topic.display_name	Chronic Lymphocytic Leukemia Research
cited_by_count	0
locations_count	1
best_oa_location.id	pmh:oai:HAL:hal-04825892v1
best_oa_location.is_oa	True
best_oa_location.source.id	https://openalex.org/S4306402512
best_oa_location.source.issn
best_oa_location.source.type	repository
best_oa_location.source.is_oa	False
best_oa_location.source.issn_l
best_oa_location.source.is_core	False
best_oa_location.source.is_in_doaj	False
best_oa_location.source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
best_oa_location.source.host_organization	https://openalex.org/I1294671590
best_oa_location.source.host_organization_name	Centre National de la Recherche Scientifique
best_oa_location.source.host_organization_lineage	https://openalex.org/I1294671590
best_oa_location.license	cc-by
best_oa_location.pdf_url
best_oa_location.version	submittedVersion
best_oa_location.raw_type	Conference papers
best_oa_location.license_id	https://openalex.org/licenses/cc-by
best_oa_location.is_accepted	False
best_oa_location.is_published	False
best_oa_location.raw_source_name	Journée d’innovation en immunologie, BIOSYNEX, Oct 2024, Paris, France
best_oa_location.landing_page_url	https://inria.hal.science/hal-04825892
primary_location.id	pmh:oai:HAL:hal-04825892v1
primary_location.is_oa	True
primary_location.source.id	https://openalex.org/S4306402512
primary_location.source.issn
primary_location.source.type	repository
primary_location.source.is_oa	False
primary_location.source.issn_l
primary_location.source.is_core	False
primary_location.source.is_in_doaj	False
primary_location.source.display_name	HAL (Le Centre pour la Communication Scientifique Directe)
primary_location.source.host_organization	https://openalex.org/I1294671590
primary_location.source.host_organization_name	Centre National de la Recherche Scientifique
primary_location.source.host_organization_lineage	https://openalex.org/I1294671590
primary_location.license	cc-by
primary_location.pdf_url
primary_location.version	submittedVersion
primary_location.raw_type	Conference papers
primary_location.license_id	https://openalex.org/licenses/cc-by
primary_location.is_accepted	False
primary_location.is_published	False
primary_location.raw_source_name	Journée d’innovation en immunologie, BIOSYNEX, Oct 2024, Paris, France
primary_location.landing_page_url	https://inria.hal.science/hal-04825892
publication_date	2024-10-01
publication_year	2024
referenced_works_count	0
abstract_inverted_index.National	0
abstract_inverted_index.audience	1
cited_by_percentile_year
corresponding_author_ids	https://openalex.org/A5088425379
countries_distinct_count	1
institutions_distinct_count	1
corresponding_institution_ids	https://openalex.org/I4210106545
citation_normalized_percentile.value	0.48061511
citation_normalized_percentile.is_in_top_1_percent	False
citation_normalized_percentile.is_in_top_10_percent	False